Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low-normal serum lactate dehydrogenase: 'The AGENDA trial'

DSpace Repository

Show simple item record

dc.contributor.author Garbe, Claus de_DE
dc.date.accessioned 2014-10-08T14:53:40Z
dc.date.available 2014-10-08T14:53:40Z
dc.date.issued 2014 de_DE
dc.identifier.issn 0960-8931 de_DE
dc.identifier.uri http://hdl.handle.net/10900/56874
dc.language.iso en en
dc.publisher Lippincott Williams & Wilkins de_DE
dc.relation.uri http://dx.doi.org/10.1097/CMR.0000000000000056 de_DE
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.title Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low-normal serum lactate dehydrogenase: 'The AGENDA trial' de_DE
dc.type Artikel de_DE
utue.quellen.id 20140813180100_00447 de_DE
utue.publikation.seiten 237-243 de_DE
utue.personen.roh Bedikian, Agop Y. de_DE
utue.personen.roh Garbe, Claus de_DE
utue.personen.roh Conry, Robert de_DE
utue.personen.roh Lebbe, Celeste de_DE
utue.personen.roh Grob, Jean J. de_DE
dcterms.isPartOf.ZSTitelID Melanoma Research de_DE
dcterms.isPartOf.ZS-Issue 3 de_DE
dcterms.isPartOf.ZS-Volume 24 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record